SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-06-018306
Filing Date
2006-03-22
Accepted
2006-03-21 17:36:35
Documents
13
Period of Report
2006-05-10
Effectiveness Date
2006-03-22

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT a06-5806_2def14a.htm DEF 14A 1122704
2 GRAPHIC g58064mahtmlonlyi001.jpg GRAPHIC 16710
3 GRAPHIC g58062hohtmlonlyi001.jpg GRAPHIC 7052
4 GRAPHIC g58062hohtmlonlyi002.gif GRAPHIC 1356
5 GRAPHIC g58062dahtmlonlyi001.jpg GRAPHIC 10148
6 GRAPHIC g58062dahtmlonlyi002.jpg GRAPHIC 2758
7 GRAPHIC g58062dci001.jpg GRAPHIC 3541
8 GRAPHIC g58062dwi001.jpg GRAPHIC 22828
9 GRAPHIC g58062dyi001.jpg GRAPHIC 3541
10 GRAPHIC g58061bai001.jpg GRAPHIC 690
11 GRAPHIC g58061bai002.jpg GRAPHIC 754
12 GRAPHIC g58061bai003.jpg GRAPHIC 701
13 GRAPHIC g58061bai004.jpg GRAPHIC 760
  Complete submission text file 0001104659-06-018306.txt   1223728
Mailing Address ONE AMGEN CENTER DRIVE MAIL STOP 27-3-C THOUSAND OAKS CA 91320-1799
Business Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320-1799 805-447-1000
AMGEN INC (Filer) CIK: 0000318154 (see all company filings)

IRS No.: 953540776 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-12477 | Film No.: 06702084
SIC: 2836 Biological Products, (No Diagnostic Substances)